Precision Medicine Market to Reach US$ 105.6 Billion by 2026, Globally |CAGR: 9.9%| UnivDatos Market Insights

NOIDA, India, Dec. 1, 2020 /PRNewswire/ — A comprehensive overview of the precision medicine market is recently added by UnivDatos Market Insights to its humongous database. The precision medicine market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, the precision medicine market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the precision medicine market at the global and regional levels. Global Precision Medicine Market is expected to grow at a CAGR of 9.9% from 2021-2026 to reach US$ 105.6 billion by 2026.

Market Overview

Precision medicine is known to be one of the most promising approaches for tackling the diseases that have thus far eluded effective treatments or cures. Several indications such as cancer, neurodegenerative diseases, and rare genetic conditions take an immense toll on individuals, families, and societies. Cancer is amongst the leading cause of mortality worldwide with an estimation of 9.6 million deaths in 2018. The most common cancers include lung (2.09 million cases), breast (2.09 million cases), colorectal (1.80 million cases), prostate (1.28 million cases), non-melanoma skin (1.04 million cases), stomach (1.03 million cases).

The rising demand for preventive care and advances in next-generation sequencing (NGS) technologies have resulted in an unprecedented proliferation and deluge of genomic sequence data, thereby driving the market growth of the precision medicine sector. In the last 15 years, the cost of mapping a human genome has fallen from US$ 100 million to below US$ 1,000, allowing the use of data from patient DNA to become a significant viable method to provide precise, actionable recommendations before symptoms occur. The growth of the industry is also fueled by scientific discovery, alignment of incentives, regulatory decisions, consumer interest and demand, and advances in technology. The growth of the market for precision medicine is also supported by the increasing patient adherence to treatment and rising prevalence of oncology indications.

Request Sample Copy of this Report @

Impact of COVID-19:

As the pandemic is spreading rapidly, clinicians treating COVID-19 are in desperate need of effective therapy, as the development of an effective vaccine remains a remote possibility. Given the urgent nature of the pandemic and the number of companies and researchers developing COVID-19 related therapies, there are more than 560 drug development programs in the pipeline with over 370 trials been reviewed by FDA. For instance, Boehringer Ingelheim initiated a Phase II study of BI 764198, a TRPC6 inhibitor to alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in patients hospitalized for COVID-19.

Ask for Price & Discounts @

Global Precision Medicine Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

By Technology, the market is primarily bifurcated into

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion
Read More

At a CAGR of 10.1% Lateral Fitness Equipment to Reach $10.7 Billion by 2027

(MENAFN – EIN Presswire)×466

Lateral Fitness Equipment Market

Market to witness significant growth due to introduction of high-tech technology such as television screen, CSAFE connectivity, iPod compatibility, sound system

Surge in number of gym memberships, rise in sale of in-home equipment, upsurge in urban population & increase in government initiatives to promote healthy life is further boost the overall revenue. — SwatiPORTLAND, OR, UNITED STATES, December 1, 2020 /[To enable links contact MENAFN] — According to a new report published by Allied Market Research, titled, ‘[To enable links contact MENAFN] Lateral Fitness Equipment Market by Type, Body Type, End User, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020–2027,’ the global lateral fitness equipment market size was valued at $5.4 billion in 2020, and is projected to reach $10.7 billion by 2027, registering a CAGR of 10.1% from 2020 to 2027. Lateral fitness equipment is any machine or device required for physical exercise to manage overall weight, improve physical stamina, and develop muscular strength. Lateral fitness equipment market demand has increased globally, due to increase in health awareness. In addition, physical exercise is advised during certain medical treatments. The most commonly used lateral fitness equipment include treadmills, elliptical, stationary bicycles weightlifting machines & strength building machines, and others.Increase in health awareness and rise in need for active, healthy lifestyle across the world majorly boost the growth of the lateral fitness equipment market. Sedentary lifestyle and changes in eating habits have led to increase in health risks. Therefore, increase in awareness toward regular physical activities to maintain healthy lifestyle fuels the growth of the lateral fitness equipment market.

Moreover, availability of smart gym equipment has made the lateral fitness exercises interesting and entertaining. Smart gym equipment is a type of equipment that is connected to an app that records workouts and also displays the data about workout. These connected gym equipment are linked to the internet and record all data such as workout goals, nutritional habits, and health history through cloud based data. This data helps in creating a personalized exercise plan and also track the workout. Furthermore, implementation of technologies like IoT and AI in lateral fitness equipment help connect the machines with smartphone, which also augment the growth of lateral fitness equipment market. In addition, treadmills, elliptical, and stationary bikes are the most popular high-tech lateral fitness machines owing to the presence of television screens, Bluetooth connectivity, iPod compatibility, sound system, CSAFE connectivity and other features. Thus, increase in implementation of high-tech features is anticipated to provide lucrative lateral fitness equipment market opportunity and eventually increase its customer base.

Download PDF Sample Report @ [To enable links contact MENAFN]

The number of social media users has increased considerably with rise in internet penetration. Taking this into consideration, most of the key players in the lateral fitness equipment market strategize on promoting their products and services on these social media platforms. Social media marketing is one of the major strategies adopted by various companies and

Read More

Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine

MELBOURNE, Australia and BAAR, Switzerland, Nov. 29, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into an agreement with Scintec Diagnostics GmbH (‘Scintec’) to acquire TheraPharm GmbH (‘TheraPharm’), a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of hematology.

The acquisition of TheraPharm provides Telix with access to a portfolio of patents, technologies, production systems, clinical data and know-how in relation to the use of Molecularly Targeted Radiation (MTR) in hematology and immunology. TheraPharm is developing antibody MTR technology against CD66, a cell surface target highly expressed by neutrophils (a type of white blood cell) and tumor-infiltrating lymphocytes. As such, the technology has potentially very broad applications in the diagnosis and treatment of hematologic diseases (e.g. blood cancers), lymphoproliferative disorders and immune-mediated diseases (e.g. lupus, and multiple sclerosis). Of particular interest is the demonstrated use of the technology to safely and effectively perform bone marrow conditioning (BMC) prior to bone marrow stem cell transplant.

Telix CEO, Dr. Christian Behrenbruch stated, “Telix is committed to extending and improving the lives of patients with serious diseases. As such, the acquisition of TheraPharm and its MTR assets are uniquely aligned to Telix’s mission and technical strengths in antibody engineering and radiochemistry. TheraPharm’s technology has a significant role to play in BMC and stem cell transplantation across a broad range of blood cancers and rare diseases. The current approach to BMC employs highly toxic drugs that have a poor morbidity and mortality profile, and for which many patients are ineligible. MTR offers an excellent safety profile that may greatly expand the number of patients able to undergo life prolonging stem cell transplantation while greatly reducing the hospitalisation burden and cost associated with such procedures.”

TheraPharm co-founder and Managing Director, Dr. Klaus Bosslet added, “Over the past 5 years, TheraPharm, in collaboration with Dr. Kim Orchard from the University of Southampton (UK), has made excellent progress developing 90Y-besilesomab for the treatment of hematologic cancers and several related conditions including multiple myeloma, leukemia and amyloidosis. This unique asset is a logical addition to Telix’s portfolio, offering a potentially rapid development path to a first commercial indication for the treatment of patients with SALA, while at the same time having potentially broad applications for stem cell transplantation in patients with more common cancers of the blood, including multiple myeloma and leukemia. We look forward to joining the Telix team in order to expedite the development of products for this under-served field.”

Full transaction details, including financial terms, can be found via the Telix website and ASX portal here.

About Hematopoietic Stem Cell Transplant (HSCT)

Bone marrow conditioning (BMC) followed by hematopoietic stem cell transplantation (HSCT) is presently performed to treat patients with hematologic malignancies (blood cancers), with the objective of extending patient survival or achieving cure. HSCT is also performed for a broad range of non-cancer conditions. HSCT is preferentially performed in countries of high income (Europe >30,000, Americas >20,000, worldwide >65,000 p.a., respectively)

Read More

Global fitness app market size valuation to reach USD 15.96 billion by 2026

Selbyville, Delaware, Nov. 24, 2020 (GLOBE NEWSWIRE) — As per reliable estimates, worldwide fitness app market size is predicted to reach USD 15.96 billion mark by 2026. Rising concerns associated with unhealthy habits, evolving consumer lifestyle, and growing obese population are some of the key factors propelling the market expansion.

The study elaborates on several market segmentations including app type, device type, OS platform type, and regional outlook. Additionally, the document conducts a thorough SWOT analysis of various companies operating in this business sphere.

The research report also analyzes the impact of COVID-19 outbreak on industry expansion graph and valuation in the ensuing years, further allowing for advanced decision-making during investment assessment.

Request Sample copy of this Report @

The surge in obese population coupled with rising adoption of sedentary lifestyle have resulted in increased pervasiveness of diseases such as hypertension and diabetes. In addition to this, rising per capita income along with increasing awareness pertaining to health and nutrition are stimulating the overall industry outlook.

According to industry analysts, the number of gym and health club memberships has significantly increased in the recent past. Additionally, rising smartphone penetration, widespread adoption of mobile devices, and easy accessibility to high-speed internet are positively impacting the remuneration scale of global fitness app market.

Availability of numerous types of fitness apps such as Sweat: Kayla Itsines Fitness and Runstatic coupled with high concentration of companies are also facilitating the business scenario. In 2015 for instance, Adidas acquired the Austrian company Runstatic in order to improve its overall market share. Thus, focus among major companies towards expanding their product portfolio through innovative launches and strategic collaborations are aiding the expansion of global fitness app market.

Highlighting the regional outlook

Global fitness app industry is bifurcated into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. According to authentic estimations, North America is expected to capture majority market share by the year 2026.

Growing population and surging disposable income are favoring the regional market outlook. Moreover, widespread adoption of sedentary lifestyle and rising health concerns have augmented the demand for fitness apps, which in turn is positively swaying the business dynamics in North America.

Meanwhile, Asia-Pacific fitness app market is set to record the highest CAGR through 2026. Factors such as growing purchasing power, rising health cognizance, high concentration of fitness centers, and increasing smartphone penetration have allowed Asia-Pacific to emerge as a major revenue generator for worldwide fitness app market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

Global Fitness App Market by App Type (Revenue, USD Billion, 2015-2026)

  • Medication Adherence
  • Lifestyle Management
  • Nutrition & Diet
  • Disease Management
  • Workout & Exercise Apps

Global Fitness App Market by Device Terrain (Revenue, USD Billion, 2015-2026)

  • Wearable Devices
  • Tablets
  • Smartphones

Global Fitness App Market by OS Platform (Revenue, USD Billion, 2015-2026)

Global Fitness App Market Regional Outlook (Revenue, USD Billion, 2015-2026)

North America


  • Netherlands
  • Russia
  • Belgium
  • Spain
Read More

Global Artificial Intelligence In Medicine Market to Reach 15,000.00 Million by 2026 – Facts & Factors

The MarketWatch News Department was not involved in the creation of this content.

New York, NY, Nov 17, 2020 (GLOBE NEWSWIRE via COMTEX) —
New York, NY, Nov. 17, 2020 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Artificial Intelligence in Medicine Market By Component (Hardware, Software, Service), By Application (Robot Assisted Surgery, Virtual Nursing Assistants, Administrative Workflow Assistance, Fraud Detection, Connected Machines, Clinical Trial, Preliminary Diagnosis, Others), By End-User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, Payer, Others), and By Technology (Querying Method, Natural Language Processing, Context Aware Processing, Speech Recognition, Decision Management, Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020-2026”.

According to the research study, the global Artificial Intelligence in Medicine Market was estimated at USD 800 million in 2019 and is expected to reach USD 15,000 million by 2026. The global Artificial Intelligence in Medicine Market is expected to grow at a compound annual growth rate (CAGR) of 49% from 2020 to 2027.

The Global Artificial Intelligence In Medicine Market Is Powered By The Need To Minimise Healthcare Costs, The Importance Of Big Data In Healthcare, The Increasing Acceptance Of Precision Medicine, And The Decreasing Hardware Costs.

Artificial intelligence in medicine is likely to transform the doctor’s character expressively and revolutionize the preparation of medicine. Across has transformed medical specialties and addresses the benefits and challenges of this new technology. Doctors, particularly those in management positions, are developing in health the need to be receptive to AI rapidly, so they remain ready to make the necessary change for their acceptance into the health system. In the study of different medical conditions, the AI is useful as individuals, and in certain circumstances, extra efficient. In the investigation of complicated medical evidence, AI in medicine is the use of compound algorithms and machines to imitate hominid reasoning. AI is, in reality, the capacity of computer systems to approximate decisions without human feedback.

Browse through 34 Tables & 97 Figures spread over 180+ Pages and in-depth TOC on “Global Artificial Intelligence in Medicine Market Size & Share 2020 Analysis and Industry Forecast to 2027”.

Request Free Sample Report of Global Artificial Intelligence in Medicine Market @

In order to recognize errors in existing scenarios and provide potential options in complicated situations, the increasingly growing use of cloud computing techniques has encouraged the adoption of artificial intelligence solutions for mining vast volumes of data. Many participants in the medical sector have promoted the use of AI technologies as it can theoretically boost the service offered by many. The key functions that involve the highest AI integration in the industry are access to documentation, the processing of patient-related symptoms, and the communication of subsequent therapies. With advanced cognitive technologies, IBM Watson is driving the transformation in the medical sector to dynamically understand, reason, and learn and commit to ensuring timely quality and informed decision-making. It has been projected that the healthcare sector

Read More

US Coronavirus Deaths May Reach 372,000 By The Time New President Takes Office


  • An IHME projection shows more than 372,000 Americans may die of COVID-19 by January 20
  • A universal mask mandate may save the lives of 1,316 people daily
  • Last Friday, the U.S. reported 99,321 new daily coronavirus cases

The U.S. may reach 372,000 coronavirus deaths by the time a new president takes the oath of office on January 20, a new prediction shows. 

More than 372,000 Americans may die of COVID-19 by that day if the current preventive measures continue, according to a projection by the Institute of Health Metrics and Evaluation (IHME). The model also shows that the total death toll in the U.S. could hit 443,335 if local governments lift coronavirus safety mandates.

The number of daily deaths could also reach 2,290 if the current coronavirus safety measures continue. However, a universal face-mask mandate could save the lives of 1,316 daily. 

The prediction comes as millions of Americans have headed to voting sites Tuesday, despite a resurgence of the novel coronavirus pandemic across the nation, which has continuously broken grim records. 

Last Friday, the U.S. set a new single-day high for the number of new coronavirus cases, with health officials reporting 99,321 new cases. Hospitalizations are also seeing an uptick, with 48,000 people currently confined in medical facilities, The COVID Tracking Project reported.  

Hospitals in several states have already hit their “breaking point.” In El Paso, Texas, authorities are now preparing to convert the city’s civic center into an overflow medical facility. They are also planning to add a fourth mobile morgue. 

Bo Ryall, the president and CEO of the Arkansas Hospital Association, said they have a lack of medical staff due to fatigue, increasing costs, and community exposure, CNN reported. 

Researchers from the IHME estimated that the country would need at least 131,208 hospital bed spaces by January 20, 33,000 of which in intensive care units. The projection also predicts that at least 14,000 invasive ventilators would be needed. 

The country’s seven-day average of new daily cases has risen by 128.2% since early September, hitting 78,380 on Saturday. Officials worry that the upcoming holidays may spur gatherings and fuel the spread of the virus. 

Health experts have emphasized the need to follow preventive measures, including face masks, social distancing, and frequent hand washing. 

The U.S. has recorded 9.3 million coronavirus cases and 232,553 deaths, according to the Johns Hopkins University Coronavirus Dashboard.  Investors are keeping a close eye on the US election, which comes against the backdrop of the coronavirus pandemic Investors are keeping a close eye on the US election, which comes against the backdrop of the coronavirus pandemic Photo: AFP / TIMOTHY A. CLARY

Source Article

Read More

Asia Pacific cannabis market is expected to reach US$ 22,870.6 million by 2027 from US$ 2,318.6 million in 2019

The market is anticipated to grow with a CAGR of 28. 6% from 2020 to 2027. The growth of the Asia Pacific cannabis market is attributed to increasing research on medical cannabis and rising cannabis industry in Southeast Asia.

New York, Nov. 03, 2020 (GLOBE NEWSWIRE) — announces the release of the report “Asia Pacific Cannabis Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Product Type ; Application ; Compound, and Country” –
However, restriction on the use of cannabis in the region is likely to hinder the market growth during the forecast period.

In recent years, the liberation for the use of cannabis in the medical industry has created various growth opportunities in Southeast Asian countries.Growing legal jurisdictions have enabled the progress of research activities in countries, such as South Korea, Australia, and New Zealand.

Also, various international companies have shown interest in effective market strategies.The companies have strategically enhanced their operational activities by partnering with local players.

For instance, a Canadian market player, Canopy Growth, has expanded its production in South Korea and Thailand.Similarly, MYM Nutraceuticals has expanded its business through its subsidiary MYM Australia.

Such expansions by the companies are expected to drive the cannabis market in the region.

Thailand is among the largest producers of cannabis.In late 2018, it became a cannabis production hub for legalized medical cannabis.

In addition, in December 2018, the military of Thailand voted to legalize medical cannabis use and in February 2019, Thailand legalized medical use of cannabis.Similarly, in January 2019, the Philippine House of Representatives approved the legalization of cannabis in the Philippines.

It has also created a Medical Cannabis Compassionate Center to initiate the creation of a legal cannabis industry.In March 2019, South Korea legalized medical use of cannabis.

Moreover, in March 2019, Japan approved the cannabis compound Epidiolex for clinical trials. Thus, such approvals for cannabis-based products are likely to drive market for cannabis in the Asia Pacific region.
On the other hand, the COVID-19 outbreak is growing in an unexpected way.For instance, according to an article published in May 2020, saying, “The study mentions how they have identified a minimum of 13 cannabis plants that are high in CBD that can affect the ACE2 pathways that the coronavirus uses to get inside one’s body”.

Therefore, it is expected to increase the use of medical cannabis to treat symptoms of COVID-19.

Based on product type, the Asia Pacific cannabis market is segmented into flower, concentrates, and others.In 2019, the flower segment held the largest market share of the cannabis market.

However, the concentrates segment is expected to witness the highest CAGR in the next few years.
In terms of application, the Asia Pacific cannabis market is segmented into medical and recreational.In 2019, the medical segment held larger share of the market.

However, the recreational segment is anticipated to witness fastest growth during the forecast period.

Based on compound, the Asia Pacific cannabis market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC

Read More

Coronavirus cases in North Dakota reach record high

The number of confirmed, active cases of the novel coronavirus in North Dakota has surged, reaching the highest levels since the deadly virus was first identified in the Midwestern state. 

As of Monday, North Dakota reported 8,440 active cases of COVID-19, the highest amount since the state began tracking cases in March. The high includes an estimated 975 newly confirmed active cases, raising the state’s daily positivity rate to 12.62%, per state health data. 

The news comes after North Dakota health officials in late October asked residents to conduct their own contact tracing if they have tested positive for COVID-19 as a surge in cases of the novel coronavirus has left contact tracers in the state overwhelmed and strapped for resources. (iStock)

The news comes after North Dakota health officials in late October asked residents to conduct their own contact tracing if they have tested positive for COVID-19 as a surge in cases of the novel coronavirus has left contact tracers in the state overwhelmed and strapped for resources. (iStock)

Overall, the state has reported more than 46,000 cases of the deadly virus and some 540 deaths. 

The news comes after North Dakota health officials in late October asked residents to conduct their own contact tracing if they have tested positive for COVID-19 as a surge in cases has left contact tracers in the state overwhelmed and strapped for resources. 


In a news release, the North Dakota Department of Health announced it added some 400 contact tracers and case investigators over the summer to help “quickly trace and quarantine close contacts, allowing contact tracing to continue long after many other states had to suspend their efforts.” 

But a “sharp increase” in COVID-19 cases in recent weeks “put increased pressure on contact tracing teams at the state and local level, leading to tracing delays and a backlog of positive cases that have yet to be assigned to a case investigator,” they said at the time. 


Officials also noted that it will take longer for those who have been tested for the novel coronavirus to learn their results. Patients will be notified 72 hours from when the lab confirms their result compared to the past wait time of 24 hours. 

“In addition, significant community spread of coronavirus and a lack of compliance with close contact investigations have diminished the effectiveness of contact tracing,” health officials said at the time. 


Source Article

Read More

Online Fitness Market Size to Reach USD 59,231 Billion by 2027 | CAGR of 33.1%

BANGALORE, India, Oct. 29, 2020 /PRNewswire/ — Online/Virtual Fitness Market by Streaming Type (Live, and On-demand), Device Type (Smart TV, Smartphones, Laptops Desktops & Tablets, and Others), Session Type (Group and Solo), Revenue Model (Subscription, Advertisement, and Hybrid) and End User (Professional Gyms, Sports Institutes, Defense Institutes, Educational Institutions, Corporate Institutions, Individuals, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027 – Published on Valuates Reports in Beauty & Fitness Category.

Valuates Reports Logo

The global Online fitness market size was valued at USD 6,046 Million in 2019 and is projected to reach USD 59,231 Million by 2027, growing at a CAGR of 33.1% from 2020 to 2027.

North America is expected to hold the largest Online Fitness Market share during the forecast period. The major factor driving the growth of North America’s market share is the increased emphasis on precision medicine and personalized treatment and the significant presence of numerous health and wellness organizations across this region.

Major factors driving the growth of online fitness market size are the need for specialized fitness sessions to achieve physical fitness, the interest of health insurance companies in online fitness services to minimize the cost of health insurance, increasing demand for fitness based on AR or VR, growing demand for healthy food.

Furthermore, recent COVID-19 has had a positive effect on the online fitness market size. The COVID-19 pandemic has disrupted people’s lives and forced fitness centers to remain closed. This scenario has, in turn, led to the rapid adoption of virtual fitness solutions as individuals have begun workouts at their homes.

Request a Sample Copy of the Report For COVID-19 Impact Analysis on Online Fitness Market:


The increase in digitalization will propel the expansion of the online fitness market size along with the trend of connected fitness equipment that allows users to monitor health parameters, such as pulse rate and calories. Several businesses are launching virtual classes that allow users to incorporate fitness experiences with their smart devices.

The rising penetration of smart devices and the internet is expected to increase the growth of the online fitness market size. The penetration of smartphones and tablets has resulted in high fitness app adoption across all demographics. Some apps provide personalized services based on specifications and body physiology.

Corporate institutions that incorporate gyms into their infrastructure would boost the demand for the online fitness industry. Several fitness clubs partner with businesses to facilitate the introduction of gyms to improve employee productivity in the work environment.

Awareness about the growing health issues due to sedentary lifestyles is fueling the online fitness market size. Increasing rates of obesity and associated disorders, including heart attacks and diabetes, enable individuals to take individual fitness lessons to cope with specific health problems.

However, interruptions in the class flow due to tech glitches, along with the lack of real contact with the teacher, may, to some degree, impede the growth of the online fitness industry.

View market snapshot before purchasing


Read More

EPA/DHA (Omega3) Ingredients Market to reach $3.8 billion by 2026, Says Global Market Insights, Inc.

EPA/DHA (Omega3) Ingredients Industry projected to register more than 7% CAGR between 2020 and 2026, impelled by increasing consumer awareness for omega-3 fortified products.

Selbyville, Delaware, Oct. 29, 2020 (GLOBE NEWSWIRE) —

The EPA/DHA (omega3) ingredients market value is expected to cross USD 3.8 Billion by 2026, according to a new research report by Global Market Insights, Inc. Growing awareness about the functional benefits of EPA/DHA ingredients and increasing and increasing health care cost is anticipated to propel the industry outlook. 

EPA/DHA (Omega3) Ingredients industry from EPA is expected to register over 8.6% CAGR through 2026, due to the virtue of increasing high quality supplements and increasing product penetration. Since, EPA fatty acid supplements help to support good heart health along with weight management, child development, and joint health. EPA metabolizes to produce hormone like substances called eicosanoids which are responsible regulating cell growth, muscle activity, hormone secretion and blood clotting. Thereby, demand for EPA/DHA(Omega3) ingredients is anticipated to grow. Moreover, rising incidences of various diseases like cardiovascular disease, diabetes and hormonal issues owing to hectic lifestyle and harmful dietary habits will boost product demand.  

Request for a sample of this research report @

The global economy is hit by COVID- 19 pandemic where, even after continuing the operations, many nations are facing challenges of resuming their production capacity and manufacturers are experiencing the effect of shortages in their distribution networks. However, increasing electricity demand and robust growth across the healthcare sector is anticipated to amplify the product installation.

Some major findings of the EPA/DHA (omega3) ingredients market report include:

  • The gradual shift of consumers towards dietary and functional food has gain traction owing to its high protein and nutrition content will foster the global Market trends.

  • Increasing incorporation of EPA/DHA ingredients in infant formulas is one of the defining trends which creates favourable market demand.

  • EPA/DHA (omega3) ingredients demand from animal & pet feed is expected to register over 9.8% CAGR through owing to increasing number of pet ownership.

  • High demand of clean label products is creating lucrative growth opportunities for the market.

  • EPA/DHA ingredients sourced from plant such as algae is likely to gain traction in the market due to increasing vegan population.

  • Key players operating in the market are continuously investing in research and development activities in order to monitor its product offerings and exhilarate ever rising demand of consumers. 

  • Increasing application scope in cancer treatment may drive the industry demand. Rise in R&D expenditure to develop omega 3 clinical nutrition products and pharmaceutical drugs should have positive influence on product demand.

  • Some of the major players operating in the market are BASF, Koninklijke DSM N.V., Croda International plc, Omega Protein, Nordic Naturals, Inc., Copeinca ASA, Epax Norway AS, Arista Industries, Inc., GC Rieber, Solutex, Olvea and Lysi others.  

Browse key industry insights spread across 300 pages with 396 market data tables and 30 figures & charts from the report, “EPA/DHA (Omega3) Ingredients Market Forecasts By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal

Read More